Cardiovascular Disease Fellowship AY 26

Target Audience

The target audience is Cardiology and Cardiovascular Disease fellows, Physician Assistants, and Cardiology faculty, as well as Morehouse School of Medicine Internal medicine and family medicine residents

Course summary
Course opens: 
09/26/2025
Course expires: 
06/19/2026
Rating: 
0
Peer reviewer(s)

Anekwe Onwuanyi

has no relevant financial relationships to disclose at this time.
Planner(s)

Tarek Jabi

has no relevant financial relationships to disclose at this time.

Anekwe Onwuanyi

has no relevant financial relationships to disclose at this time.
Speaker(s)

Jalal Ghali

has a financial relationship (Other) with Novartis;.

Elizabeth Ofili

has a financial relationship (Professional Services) with AMGEN;.
has a financial relationship (Professional Services) with NOVARTIS;.

Anekwe Onwuanyi

has no relevant financial relationships to disclose at this time.

Ambarish Pandey, MD, MS

has a financial relationship (Other) with Tricog Health Inc, Lilly USA, Rivus, Cytokinetics, Roche Diagnostics, Axon Therapies, Medtronic, Edward Lifesciences, Science37, Novo Nordisk, Bayer, Medical AI, Astra Zeneca, Baylor Scott and White Research Institute, Boehringer Ingelheim;.
has a financial relationship (Other) with Rhythm Technologies, Tourmaline Bio, Merck, Sarfez Pharmaceuticals, Semler Scientific, Ultromics, Encarda, Boehringer Ingelheim, Tenax Pharma, Alnylam, Abbott, Kieele Health, Anumana, Acorai, Novartis, Antlia Biosciences.;.

Yasir Taha, MD FACC FSCAI

has no relevant financial relationships to disclose at this time.

David Zhuo, MD, FACC, FHFSA

has no relevant financial relationships to disclose at this time.
Please login or register to take this course.